期刊文献+

炎性因子在慢性阻塞性肺疾病急性加重期的作用研究 被引量:12

The role of inflammatory factor in the exacerbation of chronic obstructive pulmonary diseases
在线阅读 下载PDF
导出
摘要 目的探讨慢性阻塞性肺疾病急性加重(AECOPD)患者治疗前后血IL-10、IL-23、CRP等炎症因子的浓度变化及其与肺功能损害的相关性。方法采用ELISA分析50例AECOPD患者治疗前后血清IL-10、IL-23、C-反应蛋白,测PaO2、FEV1、FEV1/FVC%、外周血白细胞计数和中性粒细胞百分比,分析IL-10、IL-23、CRP与FEV1和FEV1/FVC%的相关性。结果在AE-COPD患者中,治疗前后IL-10浓度分别为(179.9±73.8pg/L)和(223.5±107.8pg/L),比对照组(364.3±160.2pg/L)低;治疗前后IL-23浓度分别为(189.4±103.7pg/L)和(177.2±103.2pg/L),均比对照组(89.7±64.4pg/L)高;治疗前后CRP浓度分别为(24.1±18.2mg/L)和(10.2±4.6mg/L),均比对照组(5.6±1.9mg/L)高;差异均有统计学意义。IL-10浓度与FEV1%、FEV1/FVC变化呈正相关(r=0.782,r=0.575,P<0.05);IL-23浓度与FEV1%、FEV1/FVC呈负相关(r=-0.586,r=-0.453,P<0.05);CRP浓度与FEV1%、FEV1/FVC呈负相关(r=-0.725,r=-0.643,P<0.05)。结论AECOPD患者血IL-10浓度较对照组低,而IL-23和CRP浓度较对照组高;血IL-10、IL-23和CRP的浓度与肺功能损害程度相关。 Objective To investigate the changes of Interleukin-10 (IL-10), Interleukin-23 (IL-23) and C-reactive protein (CRP) levels in patients with acute exacerbation of chronic obstructive pulmonary diseases (AECOPD) and to analyze the correlation between the inflammatory factor and COPD. Methods The levels of IL-10, IL-23 and CRP in fifty cases of patients with AECOPD were measured by enzyme-linked immunosorbent assay. The amounts of neutrophils, PaO2 and lung function indexes such as the forced expiratory volume in one second (FEV1 ) and the forced expiratory volume in one second/forced vital capacity (FEV1/FVC) were also determined. Results From the time of beginning therapy to the time of after-therapy,the AECOPD patients showed a significant decrease in IL-10 [ (179.9 ±73.8 pg/L,223.5 ± 107.8 pg/L respectively)vs (364. 3 ± 160. 2 pg,/L) ] ,but showed a notable increase in IL-23 [ ( 189. 4 ± 103.7 pg/L, 177.2 ± 103.2 pg/L)vs(89.7 ± 64. 4 pg/L) ] and CRP [ (24. 1 ± 18.2 mg/L, 10. 2 ± 4. 6 mg/L respectively) vs(5.6 ± 1.9 mg/L) ]. After administration ,the patients showed a significant decrease in peripheral leucocyte counts [ (5.43 ± 1.1 ) vs (7.2 ±3.9 and) ] in the ratio of neutrophils [ (65 ±4. 9)vs (74. 5 ± 11.9) ] ,but showed a notable increase in arterial partial pressure of oxygen [ (66. 1 ± 8. 0 mmHg) vs (56. 5 ± 11.9 mmHg)]. In Spearman correlation analysis, serum IL-10 concentrations with FEV1% (r = 0. 782,P 〈0. 05) and FEV1/FVC (r =0. 575 ,P 〈0. 05) were positively correlated,while IL-23 and CRP with FEV1% ( r = - 0. 586,r = - 0. 725 respectively,P 〈 0. 05 ) and FEV1 / FVC ( r = - 0. 453, r = - 0. 643 respectively,P 〈 0. 05 ) were negatively correlated. Conclusion The serum IL-10 levels in the patients with AECOPD is lower than that of the healthy control group,while IL-10 and CRP levels are higher than that of the healthy control group. The damage of lung function in patients with AECOPD is associated with the serum levels of IL-10.IL-23 and CRP.
出处 《临床肺科杂志》 2008年第11期1399-1402,共4页 Journal of Clinical Pulmonary Medicine
关键词 慢性阻塞性肺疾病 白细胞介素-10 白细胞介素-23 C-反应蛋白 chronic obstructive pulmonary disease interleukin-10 interleukin-23 C-reactive protein
  • 相关文献

参考文献18

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8245
  • 2Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J, 2006,27 (2) :397 -412.
  • 3Moore K W,de Waal Malefyt R,Coffman RL,et al. Interleukin-10 and IL-10 receptor. Annu Rov Immunol,2001,19:683 - 765.
  • 4Hubbard, R and A. Tattersfield. Inhaled corticosteroids, bone mineral density and fracture in older people. Drugs Aging,2004,21:631 -8.
  • 5Allegra L, Blasi F, de Bemardi B, et al. Antibiotic treatment and base-line severity of disease in acute exacerbations of chronic bronchitis: a re-evaluation of previously published data of a placebo - controlled randomized study. Pulmpharmacol Ther,2001,14(2) :149 -55.
  • 6Sethi S, Breton J, Wynne B, et al. Efficacy and safety of pharmaeokinetically enhanced amoxicillin2clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis. Antimicrob Agents Chemother,2005,49( 1 ) :153 -60.
  • 7Romani, L. and P. Puccetti. Protective tolerance to fungi : the role of IL-10 and tryptophan catabolism. Trends Microbiol, 2006,14 (4) : 183 - 9.
  • 8Takanashi S, Hasegawa Y, Kanehira Y, et al. Interleukin-10 level in sputum is reduced in bronchial asthmas, COPD and in smokes. Eur Respir J,1999,14(2) :309 - 14.
  • 9Peter J Barnes. Mediators of Chronic Obstructive Pulmonary Disease. Pharmaeol Rev,2004,56:515 - 48.
  • 10Breen D, Wilson S,Djukanovic R,et al. Inflammatory cells in the air- ways in COPD. 2006,61:448 - 54.

二级参考文献7

共引文献8244

同被引文献193

引证文献12

二级引证文献163

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部